IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,396,250 | +44.7% | 375,000 | +150.0% | 0.94% | +34.7% |
Q2 2022 | $1,656,000 | +333.5% | 150,000 | +650.0% | 0.70% | +402.2% |
Q4 2021 | $382,000 | -89.7% | 20,000 | -86.7% | 0.14% | -85.1% |
Q3 2021 | $3,699,000 | +42.2% | 150,000 | +50.0% | 0.93% | +0.2% |
Q2 2021 | $2,602,000 | +234.0% | 100,000 | +306.5% | 0.93% | +251.7% |
Q1 2021 | $779,000 | -14.3% | 24,600 | +25.5% | 0.26% | -45.0% |
Q4 2020 | $909,000 | – | 19,600 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |